Oncology player OneCell Diagnostics raises $16-M led by Celesta Capital

Pune-based cancer diagnostics startup OneCell Diagnostics has raised USD 16 million in a Series A funding round led by Celesta Capital. The round also saw participation from Tenacity Ventures, Cedars Sinai, Eragon, and Singularity Ventures.The fresh funds will be used by the company for market expansion of its product OncoIndx Alfa (a liquid biopsy test that detects circulating tumour cells) in the US.Founded in 2021 by Mohan Uttarwar, OneCell Diagnostics is a precision oncology liquid biopsy diagnostics company which provides genomic solutions for cancer management by leveraging Next-Generation Sequencing (NGS) technology in combination with AI/ML for the multi-omics biomarkers. The company is a joint venture between India-based Actorius Innovations and Research Pvt Ltd and Silicon Valley-based Indx.ai.